Products
IP Intelligence Reports
Patexia Concierge
Patent Analyzer
Trademarks Analyzer
Litigation Analyzer
All Products
Services
Lateral Opportunities
Expert Witness
Research Studies
Strategic Partnership
All Services
IP Community
IP Community
IP Webinars
In the News
Company
About Us
Press Release
Careers
Contact Us
Login
Join
Book a Meeting
Back to All Articles
Browse articles with tag: European Union
You must be logged in to create a new article
All Articles
Mikele Bicolli
Feb 26, 2024
•
Featured
Patent Litigation
European Patent Office Accelerates Opposition Proceedings Amidst Court Actions
In an effort to fortify the European patent system and expedite the resolution of patent disputes, the European Patent Office...
Read More
1 Likes
0 Favorites
0 Comments
Mikele Bicolli
Sep 18, 2022
•
Trademark Litigation
Iceland Food vs Iceland, When A Country Battles Over Trademark Dispute (2022)
A case filed to the Grand Board of the EU Intellectual Property Office (EUIPO) on September 9, 2022, will be...
Read More
0 Likes
0 Favorites
0 Comments
Mikele Bicolli
Jul 22, 2022
CureVac Files Patent Infringement Lawsuit in Germany Against BioNTech
Two weeks ago, Curevac filed a lawsuit in the German Regional Court in Düsseldorf against BioNTech over patent infringement alleging...
Read More
0 Likes
0 Favorites
0 Comments
Mikele Bicolli
Jun 9, 2022
Apple Loses 'Think Different' Trademark Rights in the EU
Just yesterday, the European Union's Court of Justice ruled that Apple isn’t the only company allowed to use this trademark...
Read More
0 Likes
0 Favorites
0 Comments
Mikele Bicolli
Oct 24, 2021
Do First to File Systems Encourage Trademark Squatting?
One of the reasons that the majority of countries in the world apply the “first to file” system, including the...
Read More
0 Likes
0 Favorites
0 Comments
Knobbe Martens
Jan 11, 2018
•
Featured
Report Finds European Union’s Assessment of High-Risk Medical Devices of Low Quality
A report appearing in the December 2017 issue of Value in Health, (a journal of the International Society for Pharmacoeconomics...
Read More
0 Likes
0 Favorites
0 Comments
<
1
2
>